Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
P-53 IMMUNE-MEDIATED ADVERSE EVENTS FOLLOWING ATEZOLIZUMA... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
P-53 IMMUNE-MEDIATED ADVERSE EVENTS FOLLOWING ATEZOLIZUMAB PLUS BEVACIZUMAB IS ASSOCIATED WITH DECREASED SURVIVAL IN PATIENTS WITH CIRRHOSIS
0
Authors
Federico Piñero
21 more
Federico Piñero
•
Margarita Anders
19 more
•
Manuel Mendizábal
Published
December 1, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Annals of Hepatology
Topics
Medicine
Cancer Oncology
Immunology
Internal Medicine
Gastroenterology
Show all topics
DOI
10.1016/j.aohep.2024.101667
License
CC-BY-NC-ND
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Annals of Hepatology
Topics
Medicine
Cancer Oncology
Immunology
Internal Medicine
Gastroenterology
Show all topics
DOI
10.1016/j.aohep.2024.101667
License
CC-BY-NC-ND
